StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.89+0.02 (+0.52%)

Close on Nov 18, 2026Market cap $161.81MP/E 0.9Yield 6.43%

Oramed Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Oramed Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2025 was 3202.5%. For fiscal 2025 it was 3202.5%, against 379.7% the year before. The highest annual figure on record is 3202.5% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20253202.5%+2822.8
FY2023Dec 31, 2023379.7%+1230.2
FY2021Aug 31, 2021-850.5%−425.7
FY2020Aug 31, 2020-424.8%+106.3
FY2019Aug 31, 2019-531.1%−11.4
FY2018Aug 31, 2018-519.7%−93.0
FY2017Aug 31, 2017-426.7%+1283.7
FY2016Aug 31, 2016-1710.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2025CQ1 2025Mar 31, 2025-382.1%+382.5
Q2 FY2023CQ2 2023Jun 30, 2023-177.2%+515.8
Q1 FY2023CQ1 2023Mar 31, 2023-509.8%+316.6
Q4 FY2021CQ3 2021Aug 31, 2021-1113.3%−673.4
Q3 FY2021CQ2 2021May 31, 2021-764.6%−429.2
Q2 FY2021CQ1 2021Feb 28, 2021-692.9%−145.8
Q1 FY2021CQ4 2020Nov 30, 2020-826.4%−449.1
Q4 FY2020CQ3 2020Aug 31, 2020-439.9%+3441.1
Q3 FY2020CQ2 2020May 31, 2020-335.4%−932.5
Q2 FY2020CQ1 2020Feb 29, 2020-547.2%−73.0
Q1 FY2020CQ4 2019Nov 30, 2019-377.3%+328.4
Q4 FY2019CQ3 2019Aug 31, 2019-3881.1%−3398.3
Q3 FY2019CQ2 2019May 31, 2019597.1%+1011.3
Q4 FY2018CQ3 2018Aug 31, 2018-474.2%−38.0
Q3 FY2018CQ2 2018May 31, 2018-705.7%−387.2
Q2 FY2018CQ1 2018Feb 28, 2018-482.8%+38.2
Q1 FY2018CQ4 2017Nov 30, 2017-414.2%+17.9
Q4 FY2017CQ3 2017Aug 31, 2017-436.2%+1411.8
Q3 FY2017CQ2 2017May 31, 2017-318.5%+1135.9
Q2 FY2017CQ1 2017Feb 28, 2017-520.9%–
Q1 FY2017CQ4 2016Nov 30, 2016-432.1%–
Q4 FY2016CQ3 2016Aug 31, 2016-1848.0%–
Q2 FY2016CQ1 2016Feb 29, 2016-1454.4%–

More Oramed Pharmaceuticals figures

See a number that looks wrong?